Inventiva S.A. American Depository Shares (IVA) is a publicly traded Healthcare sector company. As of October 24, 2026, IVA trades at $3.68 with a market cap of $850.45M and a P/E ratio of 0.00. IVA moved +3.06% today. Year to date, IVA is -19.35%; over the trailing twelve months it is -36.80%. Its 52-week range spans $2.67 to $7.98. Analyst consensus is strong buy with an average price target of $15.50. Rallies surfaces IVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inventiva to present new lanifibranor Phase 3 NATiV3 MASH trial data in Q4 update, AASLD abstracts show: Inventiva said three scientific posters on lanifibranor for MASH will be presented at AASLD The Liver Meeting 2026. Topline results from the Phase 3 NATiV3 trial are expected in the fourth quarter of this year.
| Metric | Value |
|---|---|
| Price | $3.68 |
| Market Cap | $850.45M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.98 |
| 52-Week Low | $2.67 |
| Volume | 4.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover IVA: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.50.